Uromigos-Kidney Cancer

Advertisement
The UromigosThe Uromigos | June 10, 2024
Drs. Nobuaki Matsubara, Hiroshi Kitamura and Yuji Miura answer trivia questions set by Tom and Brian for the Uromigos Cup.
Listen Now
The UromigosThe Uromigos | June 21, 2024
Dr. Laurence Albiges discusses this biomarker which may have predictive and prognostic capabilities for kidney cancer.
The UromigosThe Uromigos | June 21, 2024
Toni Choueiri and Brian describe similarities and differences in the biomarker findings of the KN426 and CLEAR trials.
The UromigosThe Uromigos | May 30, 2024
Drs. Danny Heng, Christian Kollmannsberger and Kala Sridhar attempt to take on Team LA to win the Uromigos Cup.
The UromigosThe Uromigos | June 6, 2024
Silke Gillessen joins Brian and Tom to give a preview of this year's ASCO annual meeting.
The UromigosThe Uromigos | June 21, 2024
The Uromigos discuss adjuvant therapy in kidney and bladder cancer trials including KEYNOTE-564.
The UromigosThe Uromigos | March 14, 2024
Dr. McDermott discusses the similarities between current melanoma trials and kidney cancer treatments.
The UromigosThe Uromigos | January 30, 2024
Dr. Bergerot describes her modifications of existing quality of life models, and Tom explains LITESPARK-005's QoL data.
The UromigosThe Uromigos | January 30, 2024
Dr. Pedro Barata gives an overview of the CheckMate 914 trial on adjuvant nivolumab plus ipilimumab for localized RCC.
The UromigosThe Uromigos | January 11, 2024
Cristina Suarez discusses the biggest RCC trials of 2023.
The UromigosThe Uromigos | January 12, 2024
Tian Zhang joins the podcast to give an overview of some of the panels presented at this year's IKCS meeting.
The UromigosThe Uromigos | November 13, 2023
Xinan Sheng, MD, joins the podcast to discuss the RENOTORCH trial on toripalimab plus axitinib for advanced RCC.
The UromigosThe Uromigos | October 30, 2023
Dr. Lisa Pickering discusses 3 different renal cancer abstracts that were presented at ESMO 2023.
The UromigosThe Uromigos | October 16, 2023
Dr. Toni Choueiri discusses progress in systemic therapy for papillary renal cell carcinoma, as well as personalized therapy.
The UromigosThe Uromigos | September 19, 2023
Dr. Celeste Simon discusses her career in translational science and kidney cancer at the University of Pennsylvania.
The UromigosThe Uromigos | September 20, 2023
Dr. Laurence Albiges discusses biomarker studies and new combinations and therapies presented at the KCRS23 meeting.
The UromigosThe Uromigos | September 19, 2023
Rachel Giles, MD, PhD, describes her patient data on adjuvant and first line treatments in renal cell carcinoma.
The UromigosThe Uromigos | July 25, 2023
Meredith Regan and David McDermott finalize their debate on VEGF/TKI vs IPI/NIVO for mRCC. PFS2 and TFS are also covered.
The UromigosThe Uromigos | July 6, 2023
Bob Motzer, MD, joins the discussion on IPI/Nivo versus VEGF/PD1 to give his perspective on the recent debate from ASCO 2023.
The UromigosThe Uromigos | June 21, 2023
The Uromigos discuss ipi/nivo combination therapy versus VEGF TKI I/O immune therapy for ccRCC with Mike Atkins, MD.
Advertisement
Advertisement
Advertisement